Patents Assigned to FuturaGene Israel, Ltd.
  • Patent number: 11555195
    Abstract: Constructs for genetically engineering plants to selectively alter DELLA gene expression to promote plant growth while maintaining root integrity are provided, as are methods of designing, making and using such constructs.
    Type: Grant
    Filed: September 17, 2018
    Date of Patent: January 17, 2023
    Assignee: Futuragene Israel Ltd.
    Inventors: Miron Abramson, Tany Sinai, Sivan Livne
  • Patent number: 10407692
    Abstract: A nucleic acid expression vector comprising a nucleic acid sequence encoding a dominant negative T3SS protein is disclosed. The nucleic acid expression vector further comprising a cis acting regulatory element capable of driving transcription of the nucleic acid sequence in a plant cell. Moreover, the dominant negative T3SS protein mediates assembly of a dysfunctional needle complex.
    Type: Grant
    Filed: May 28, 2017
    Date of Patent: September 10, 2019
    Assignee: Futuragene Israel Ltd.
    Inventors: Hanan Stein, Dror Avisar
  • Patent number: 10155959
    Abstract: The present invention relates to the field of RNA-mediated gene silencing in insect species. The present invention is based, in part, on the inventors' sequencing of genes from eucalyptus invasive species Bronze bug pest, Thaumastocoris peregrinus. In certain aspects, the invention provides Bronze bug nucleic acids, derivatives thereof and the use of such nucleic acids and derivatives as Bronze bug control agents.
    Type: Grant
    Filed: April 19, 2013
    Date of Patent: December 18, 2018
    Assignee: Futuragene Israel Ltd.
    Inventors: Dror Avisar, Daniel Siegel, Ziv Shani
  • Patent number: 10011846
    Abstract: The present invention provides a bio-fuel, wood or other product, such as a paper, textile or yarn product. The product can contain material from a transgenic plant over-expressing a nucleic acid molecule encoding an enzyme that causes the plant cell wall to be more water soluble than the wild type.
    Type: Grant
    Filed: March 26, 2008
    Date of Patent: July 3, 2018
    Assignees: Futuragene Israel Ltd., Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.
    Inventors: Oded Shoseyov, Ziv Shani, Miron Abramson
  • Patent number: 9970022
    Abstract: The present invention relates to the field of RNA-mediated gene silencing in insect species. The present invention is based, in part, on the inventors' sequencing of genes from eucalyptus invasive species gall wasp pests Leptocybe invasa (Li) and Ophelimus maskelli (Om). In certain aspects, the invention provides Li and Om nucleic acids, derivatives thereof and the use of such nucleic acids and derivatives as gall wasp control agents.
    Type: Grant
    Filed: March 30, 2012
    Date of Patent: May 15, 2018
    Assignee: Futuragene Israel Ltd.
    Inventors: Dror Avisar, Hanan Stein, Ziv Shani, Daniel Siegel
  • Patent number: 9856492
    Abstract: A nucleic acid expression vector comprising a nucleic acid sequence encoding a dominant negative T3SS protein is disclosed. The nucleic acid expression vector further comprising a cis acting regulatory element capable of driving transcription of the nucleic acid sequence in a plant cell. Moreover, the dominant negative T3SS protein mediates assembly of a dysfunctional needle complex.
    Type: Grant
    Filed: March 1, 2012
    Date of Patent: January 2, 2018
    Assignee: Futuragene Israel Ltd.
    Inventors: Hanan Stein, Dror Avisar
  • Publication number: 20170260542
    Abstract: A nucleic acid expression vector comprising a nucleic acid sequence encoding a dominant negative T3SS protein is disclosed. The nucleic acid expression vector further comprising a cis acting regulatory element capable of driving transcription of the nucleic acid sequence in a plant cell. Moreover, the dominant negative T3SS protein mediates assembly of a dysfunctional needle complex.
    Type: Application
    Filed: May 28, 2017
    Publication date: September 14, 2017
    Applicant: Futuragene Israel Ltd.
    Inventors: Hanan STEIN, Dror AVISAR
  • Publication number: 20150259701
    Abstract: The present invention relates to the field of doublestranded RNA (dsRNA)-mediated gene silencing in insect species. The present invention is based, in part, on the inventors' sequencing of genes from eucalyptus invasive species gall wasp pests Leptocybe invasa (Li) and Ophelimus maskelli (Om). In certain aspects, the invention provides Li and Om nucleic acids, derivatives thereof and the use of such nucleic acids and derivatives as gall wasp control agents.
    Type: Application
    Filed: October 2, 2013
    Publication date: September 17, 2015
    Applicant: Futuragene Israel Ltd.
    Inventor: Dror Avisar
  • Publication number: 20150082482
    Abstract: The present invention relates to the field of RNA-mediated gene silencing in insect species. The present invention is based, in part, on the inventors' sequencing of genes from eucalyptus invasive species Bronze bug pest, Thaumastocoris peregrinus. In certain aspects, the invention provides Bronze bug nucleic acids, derivatives thereof and the use of such nucleic acids and derivatives as Bronze bug control agents.
    Type: Application
    Filed: April 19, 2013
    Publication date: March 19, 2015
    Applicant: Futuragene Israel Ltd.
    Inventors: Dror Avisar, Daniel Siegel, Ziv Shani
  • Publication number: 20140157455
    Abstract: The present invention relates to the field of RNA-mediated gene silencing in insect species. The present invention is based, in part, on the inventors' sequencing of genes from eucalyptus invasive species gall wasp pests Leptocybe invasa (Li) and Ophelimus maskelli (Om). In certain aspects, the invention provides Li and Om nucleic acids, derivatives thereof and the use of such nucleic acids and derivatives as gall wasp control agents.
    Type: Application
    Filed: March 30, 2012
    Publication date: June 5, 2014
    Applicant: FUTURAGENE ISRAEL LTD.
    Inventors: Dror Avisar, Hanan Stein, Ziv Shani, Daniel Siegel
  • Publication number: 20130347141
    Abstract: A nucleic acid expression vector comprising a nucleic acid sequence encoding a dominant negative T3SS protein is disclosed. The nucleic acid expression vector further comprising a cis acting regulatory element capable of driving transcription of the nucleic acid sequence in a plant cell. Moreover, the dominant negative T3SS protein mediates assembly of a dysfunctional needle complex.
    Type: Application
    Filed: March 1, 2012
    Publication date: December 26, 2013
    Applicant: FUTURAGENE ISRAEL LTD.
    Inventors: Hanan Stein, Dror Avisar
  • Publication number: 20130097731
    Abstract: An isolated polynucleotide is disclosed comprising: (i) a nucleic acid sequence encoding at least one toxic peptide, the toxic peptide being a spider toxin; and (ii) a nucleic acid sequence encoding a chitinase attached to a secretion signal sequence. Uses thereof and plants expressing same are also disclosed.
    Type: Application
    Filed: June 16, 2011
    Publication date: April 18, 2013
    Applicant: Futuragene Israel Ltd.
    Inventors: Dror Avisar, Hanan Stein, Ziv Shani
  • Patent number: 8013211
    Abstract: The invention relates to stinging cells or isolated capsules and to their use in compositions and methods for efficient delivery of biologically active agents into a plant cell or plant tissue. The biologically active agent to be delivered by the methods of the present invention is selected from a nucleic acid, a peptide, a polypeptide, a plant hormone, an enzyme, an herbicidal agent, an anti-viral agent, an anti-bacterial agent and an anti-fungal agent. Particularly, the invention is related to compositions and methods for the efficient transformation of polynucleotide construct into a plant cell or tissue, to obtain transgenic plants.
    Type: Grant
    Filed: July 5, 2006
    Date of Patent: September 6, 2011
    Assignee: FuturaGene Israel, Ltd.
    Inventor: Ziv Shani